Literature DB >> 27658699

EBV, an inhibited receptor kinase, and lymphoma.

Richard F Ambinder1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27658699      PMCID： PMC5034736          DOI： 10.1182/blood-2016-08-724955

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  The expanding spectrum of EBV+ lymphomas.

Authors:  Jonathan Said
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

Review 2.  Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

Authors:  Riccardo Dolcetti; Jessica Dal Col; Debora Martorelli; Antonino Carbone; Eva Klein
Journal:  Semin Cancer Biol       Date:  2013-08-03       Impact factor: 15.707

3.  EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.

Authors:  Alina Nicolae; Stefania Pittaluga; Shahed Abdullah; Seth M Steinberg; Thu Anh Pham; Theresa Davies-Hill; Liqiang Xi; Mark Raffeld; Elaine S Jaffe
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

4.  Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.

Authors:  Pierre Saintigny; Shaohua Peng; Li Zhang; Banibrata Sen; Ignacio I Wistuba; Scott M Lippman; Luc Girard; John D Minna; John V Heymach; Faye M Johnson
Journal:  Mol Cancer Ther       Date:  2012-07-17       Impact factor: 6.261

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.

Authors:  Ya-Chi Huang; Sue-Jane Lin; Kai-Min Lin; Ya-Ching Chou; Chung-Wu Lin; Shan-Chi Yu; Chi-Long Chen; Tang-Long Shen; Chi-Kuan Chen; Jean Lu; Mei-Ru Chen; Ching-Hwa Tsai
Journal:  Blood       Date:  2016-06-23       Impact factor: 22.113

Review 7.  The curious case of the tumour virus: 50 years of Burkitt's lymphoma.

Authors:  David A Thorley-Lawson; Martin J Allday
Journal:  Nat Rev Microbiol       Date:  2008-12       Impact factor: 60.633

8.  EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.

Authors:  Xuefeng Jing; Takashi Sonoki; Masayasu Miyajima; Takahiro Sawada; Nanako Terada; Shigeki Takemura; Kazushige Sakaguchi
Journal:  Cancer Med       Date:  2016-02-29       Impact factor: 4.452

9.  EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.

Authors:  Miguel A Flores; Paula Fortea; Eva M Trinidad; Dolores García; Gloria Soler; Francisco J Ortuño; Agustín G Zapata; Luis M Alonso-Colmenar
Journal:  Oncotarget       Date:  2016-07-26
  9 in total
  1 in total

Review 1.  Long non-coding RNAs in Epstein-Barr virus-related cancer.

Authors:  Yitong Liu; Zhizhong Hu; Yang Zhang; Chengkun Wang
Journal:  Cancer Cell Int       Date:  2021-05-25       Impact factor: 5.722
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.